FdaApplication
ANDA 062718
Identifiers
- fda_app_no: ANDA062718
Properties
| Property | Value |
|---|---|
| applicant_name | WYETH AYERST LABORATORIES |
| application_type | ANDA |
| approval_date | 1986-12-16 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OMNIPEN-N | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE;INJECTION |
| OMNIPEN-N | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
| OMNIPEN-N | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION |
| OMNIPEN-N | AMPICILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE;INJECTION |
| OMNIPEN-N | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
5 products